Nonsecretory plasma cell myeloma - Becoming even more rare with serum free light-chain assay - A brief review

被引:0
|
作者
Shaw, Gene R. [1 ]
机构
[1] Marshfield Labs, Marshfield, WI 54449 USA
关键词
D O I
暂无
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
Context-Nonsecretory plasma cell myeloma is characterized by an absence of detectable monoclonal protein in both the serum and urine. It is generally reported to comprise approximately 1% to 5% of all cases of plasma cell myeloma and, because of its rarity, requires a high index of suspicion and bone marrow biopsy to establish the diagnosis. Objective.-Review the diagnostic strategy when nonsecretory plasma cell myeloma is a clinical consideration in light of a relatively new serum free light chain assay. Data Sources.-Case study and review of the literature. Conclusions.-Initial data using a recently developed nephelometric serum free light chain assay suggests that only about one fourth of nonsecretory plasma cell myeloma cases may be truly nonsecretory. The definition of nonsecretory plasma cell myeloma should be modified to exclude cases with evidence of clonality using the serum free light chain assay.
引用
收藏
页码:1212 / 1215
页数:4
相关论文
共 50 条
  • [41] SERUM-FREE LIGHT-CHAINS (SFLC) INSTEAD OF URINE PROTEIN ELECTROPHORESIS (UPEP) FOR MONITORING LIGHT-CHAIN MULTIPLE MYELOMA (LCMM)
    Anglada Fernandez, L. Lopez
    Cueto-Felqueroso, C.
    Mateos, M. V.
    Rosinol, L.
    Oriol, A.
    Teruel, A. I.
    Palomera, L.
    Arriba, F.
    Bargay, J. J.
    Hernandez, J. M.
    Gonzalez, Y.
    Maria Jesus, B.
    Valeri, A.
    Granell, M.
    Garcia Sanz, R.
    Lopez de la Guia, A.
    Besalduch, J.
    Martinez, R. B.
    Hernandez, M. T.
    Puerta, P.
    Blade, J.
    San Miguel, J.
    Lahuerta, J. J.
    Martinez-Lopez, J.
    [J]. HAEMATOLOGICA, 2017, 102 : 524 - 524
  • [42] Multiple Myeloma with Systemic Amyloidosis: Serum Free Light Chain Dimerization Analysis in the Diagnosis of an Equivocal Case of Plasma Cell Dyscrasia
    Duek, Adrian
    Kaplan, Batia
    Segman, Yafit
    Leiba, Merav
    [J]. ISRAEL MEDICAL ASSOCIATION JOURNAL, 2021, 23 (07): : 459 - 461
  • [43] Free light chain assay and stringent complete remission in multiple myeloma: more questions than answers Response
    Fernandez de larrea, Carlos
    Teresa Cibeira, Maria
    Elena, Montserrat
    Ignacio Arostegui, Juan
    Rosinol, Laura
    Rovira, Montserrat
    Filella, Xavier
    Yaguee, Jordi
    Blade, Joan
    [J]. BLOOD, 2010, 115 (16) : 3414 - 3415
  • [44] Comparison of three different serum-free light-chain assays-implications on diagnostic and therapeutic monitoring of multiple myeloma
    Schieferdecker, Aneta
    Hoerber, Sebastian
    Ums, Monika
    Besemer, Britta
    Bokemeyer, Carsten
    Peter, Andreas
    Weisel, Katja
    [J]. BLOOD CANCER JOURNAL, 2020, 10 (01)
  • [45] Light-chain plasma cell myeloma caused by 14q32/IGH translocation and loss of the other allele
    Yuji Nishio
    Hirotaka Sakai
    Yusuke Saiki
    Akiko Uchida
    Yu Uemura
    Manabu Matsunawa
    Yasushi Isobe
    Masayuki Kato
    Naoto Tomita
    Ikuo Miura
    [J]. International Journal of Hematology, 2019, 109 : 572 - 577
  • [46] Light-chain plasma cell myeloma caused by 14q32/IGH translocation and loss of the other allele
    Nishio, Yuji
    Sakai, Hirotaka
    Saiki, Yusuke
    Uchida, Akiko
    Uemura, Yu
    Matsunawa, Manabu
    Isobe, Yasushi
    Kato, Masayuki
    Tomita, Naoto
    Miura, Ikuo
    [J]. INTERNATIONAL JOURNAL OF HEMATOLOGY, 2019, 109 (05) : 572 - 577
  • [47] Defining complete response in multiple myeloma: Role of the serum free light chain assay and multiparameter flow cytometry
    Owen, Roger G.
    Child, J. Anthony
    Rawstron, Andy C.
    Bell, Sue
    Cocks, Kim
    Davies, Faith E.
    Jackson, Graham H.
    Morgan, Gareth J.
    Drayson, Mark T.
    [J]. BLOOD, 2007, 110 (11) : 443A - 443A
  • [48] Role of serum-free light chain assay for defining response and progression in immunoglobulin secretory multiple myeloma
    Tacchetti, Paola
    Rocchi, Serena
    Zamagni, Elena
    Barbato, Simona
    Rizzello, Ilaria
    De Cicco, Gabriella
    Pantani, Lucia
    Mancuso, Katia
    Fusco, Alessio
    Dozza, Luca
    Ursi, Margherita
    Favero, Emanuele
    Terragna, Carolina
    Testoni, Nicoletta
    Cavo, Michele
    [J]. AMERICAN JOURNAL OF HEMATOLOGY, 2022, 97 (12) : 1607 - 1615
  • [49] Serum free light chain [FLC] assay in multiple myeloma patients who achieved negative immunofixation after allogeneic stem cell transplantation
    Moesbauer, U
    Schieder, H
    Renges, H
    Ayuk, F
    Zander, A
    Kröger, N
    [J]. BLOOD, 2005, 106 (11) : 572A - 572A
  • [50] Serum Free Light Chain Assay Measurement at Disease Relapse for Prognostication in Patients with Multiple Myeloma in the Novel Agent Era
    Abe, Yoshiaki
    Narita, Kentaro
    Kobayashi, Hiroki
    Kitadate, Akihiro
    Takeuchi, Masami
    Matsue, Kosei
    [J]. BLOOD, 2017, 130